These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17824812)

  • 1. The role of nitric oxide in the maintenance of vasoactive balance.
    Pechánová O; Simko F
    Physiol Res; 2007; 56 Suppl 2():S7-S16. PubMed ID: 17824812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis.
    Schulman IH; Zhou MS; Raij L
    Curr Hypertens Rep; 2005 Feb; 7(1):61-7. PubMed ID: 15683588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
    Zhou MS; Hernandez Schulman I; Pagano PJ; Jaimes EA; Raij L
    Hypertension; 2006 Jan; 47(1):81-6. PubMed ID: 16344366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of nitric oxide in different models of experimental hypertension.
    Török J
    Physiol Res; 2008; 57(6):813-825. PubMed ID: 19154086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Working under pressure: the vascular endothelium in arterial hypertension.
    Spieker LE; Noll G; Ruschitzka FT; Maier W; Lüscher TF
    J Hum Hypertens; 2000; 14(10-11):617-30. PubMed ID: 11095155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial dysfunction].
    Nagy J; Csiky B; Kovács T; Wittmann I
    Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.
    Zhao Y; Flavahan S; Leung SW; Xu A; Vanhoutte PM; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H358-63. PubMed ID: 25485905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.
    Barton M
    Pflugers Arch; 2010 Oct; 460(5):825-37. PubMed ID: 20635093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.
    Xiao X; Zhang C; Ma X; Miao H; Wang J; Liu L; Chen S; Zeng R; Chen Y; Bihl JC
    Exp Cell Res; 2015 Aug; 336(1):58-65. PubMed ID: 26101159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Participation of endothelium-derived vasoconstrictor factors in arterial hypertension].
    Lahera V; Navarro-Cid J; Maeso R; Cachofeiro V
    Rev Esp Cardiol; 1999; 52 Suppl 3():4-11. PubMed ID: 10614144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE; DiGennaro F; Giani JF; Dominici FP
    Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension.
    Martínez-Revelles S; Avendaño MS; García-Redondo AB; Alvarez Y; Aguado A; Pérez-Girón JV; García-Redondo L; Esteban V; Redondo JM; Alonso MJ; Briones AM; Salaices M
    Antioxid Redox Signal; 2013 Jan; 18(1):51-65. PubMed ID: 22671943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation.
    Ulker S; McMaster D; McKeown PP; Bayraktutan U
    Cardiovasc Res; 2003 Aug; 59(2):488-500. PubMed ID: 12909332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
    Liu L; Liu J; Huang Y
    J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roles of vasoactive factors synthetized by endothelium in pulmonary arterial hypertension].
    Lévy M; Sabry S; Mercier JC; Dinh-Xuan AT
    Arch Pediatr; 1997 Mar; 4(3):271-7. PubMed ID: 9198532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
    Mélon P
    Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H oxidase and endothelial dysfunction.
    Muller G; Morawietz H
    Horm Metab Res; 2009 Feb; 41(2):152-8. PubMed ID: 18816427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.